{"nct_id":"NCT05984277","title":"A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-10-24","start_date_type":"ACTUAL","primary_completion_date":"2028-04-24","primary_completion_date_type":"ESTIMATED","completion_date":"2029-03-23","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}